Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pericle

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1994
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4F Pericle, M Giovarelli, M P Colombo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
HIV-1 infection induces a selective reduction in STAT5 protein expressionF Pericle, L A Pinto, S Hicks, et al.
Human Gene Therapy|October 30, 1998
Nonviral interferon alpha gene therapy inhibits growth of established tumors by eliciting a systemic immune responseM Coleman, S Muller, A Quezada, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1994
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4F Pericle, M Giovarelli, M P Colombo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
HIV-1 infection induces a selective reduction in STAT5 protein expressionF Pericle, L A Pinto, S Hicks, et al.
Human Gene Therapy|October 30, 1998
Nonviral interferon alpha gene therapy inhibits growth of established tumors by eliciting a systemic immune responseM Coleman, S Muller, A Quezada, et al.
Pageof 3